rs539612316
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000613296.6(ALMS1):c.2819T>A(p.Leu940Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,610 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L940L) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000613296.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALMS1 | NM_001378454.1 | c.2819T>A | p.Leu940Ter | stop_gained | 8/23 | ENST00000613296.6 | NP_001365383.1 | |
ALMS1 | NM_015120.4 | c.2822T>A | p.Leu941Ter | stop_gained | 8/23 | NP_055935.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALMS1 | ENST00000613296.6 | c.2819T>A | p.Leu940Ter | stop_gained | 8/23 | 1 | NM_001378454.1 | ENSP00000482968 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151822Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248598Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134860
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461788Hom.: 0 Cov.: 40 AF XY: 0.0000289 AC XY: 21AN XY: 727196
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151822Hom.: 0 Cov.: 33 AF XY: 0.0000270 AC XY: 2AN XY: 74164
ClinVar
Submissions by phenotype
Alstrom syndrome Pathogenic:5
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change creates a premature translational stop signal (p.Leu941*) in the ALMS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALMS1 are known to be pathogenic (PMID: 17594715). This variant is present in population databases (rs539612316, gnomAD 0.006%). This premature translational stop signal has been observed in individuals with Alstrom syndrome (PMID: 26111748, 27665122). ClinVar contains an entry for this variant (Variation ID: 224801). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | research | Diagnostics Division, CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS | Dec 01, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 06, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory of Medical Genetics (UMR_S 1112), INSERM/Strasbourg University | Aug 09, 2022 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 15, 2023 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25846608, 26111748, 32503575, 27665122, 35211159) - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Dec 09, 2018 | - - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 06, 2021 | The p.L941* pathogenic mutation (also known as c.2822T>A), located in coding exon 8 of the ALMS1 gene, results from a T to A substitution at nucleotide position 2822. This changes the amino acid from a leucine to a stop codon within coding exon 8. This mutation (also referred to as c.2816T>A, p.L939*) has been detected in the homozygous state and in the compound heterozygous state with ALMS1 nonsense and frameshift alleles in individuals with Alstrom syndrome (Marshall JD et al. Hum Mutat, 2015 Jul;36:660-8; Das Bhowmik A et al. Obes Res Clin Pract , 2017 Sep;11:241-246; Baig S et al. Orphanet J Rare Dis, 2020 06;15:139). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at